Abstract: The present invention relates to a pharmaceutical composition comprising a hydroquinone derivative of general formula 1 as an active ingredient. The pharmaceutical composition has the effects of: enabling the prevention or treatment of obesity by inhibiting weight gain and visceral fat accumulation; and enabling the prevention or treatment of nonalcoholic steatohepatitis by inhibiting fat accumulation in liver tissue and lobular inflammation, and by improving insulin resistance.
Type:
Application
Filed:
September 9, 2019
Publication date:
December 23, 2021
Applicant:
BIOTOXTECH CO., LTD.
Inventors:
Jong Koo KANG, Suk Mo KANG, Heung Mo BAE